side effects of dsip (Delta Sleep-Inducing Peptide) DSIP Peptide: The Sleep-Optimizing Molecule

About the study The Phase 2 study (NCT06230523) was a 48-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of once-weekly eloralintide monotherapy with placebo in adults with obesity or overweight and at least one weight-related comorbidity and without type 2 diabetes

Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

GIULIA Mandie is very knowledgeable, professional and highly skilled

In this article, we explore the science behind HOCl and its application in managing eczema